Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 3,897

Document Document Title
WO/2018/003822A1
[Problem] To provide a slipperiness-imparting agent capable of imparting durable slipperiness (in particular, slipperiness when wet). [Solution] The present invention was completed upon the discovery that a slipperiness-imparting agent c...  
WO/2018/003821A1
Provided are: a copolymer having sufficient biocompatibility for use in medical material applications; and a method for forming a cross-linked body that uses said copolymer and imparts biocompatibility to a substrate surface. More specif...  
WO/2017/221172A2
A process for producing a medical device (100), which is coated with a thin film based on carbon, comprises the steps of: - positioning a medical device to be coated inside a processing chamber (3), in which there is provided a target el...  
WO/2017/218987A1
A highly portable advanced adult and pediatric compact ECLS system is based around an integrated pump-oxygenator. The system includes a central a blood inlet and flow path extending along a general longitudinal axis of the system; a pump...  
WO/2017/210537A1
Methods of increasing immunogenic cell viability by administering an immunogenic animal cell and a complement inhibitor to a subject are described. Immunogenic animal cells such as stem cells protected with a coating of complement inhibi...  
WO/2017/190290A1
A medical polymer device comprising a biodegradable polymer is provided, wherein the biodegradable polymer has a crystallinity of about 10%to about 80%, and preferably from about 20%to about 60%, wherein the medical polymer devic...  
WO/2017/190152A1
Sustained release drug delivery devices including scaffolds comprising combinations of anti-connexin, anti-gap junction, anti-hemichannel and/or other agents, for example, anti-connexin 26 and anti-connexin43 polynucleotides or peptidomi...  
WO/2017/189480A1
The present invention relates to novel compositions and methods for reducing or eliminating the thrombogenicity of a graft by modifying the graft with a cell-derived extracellular matrix lacking thrombospodin-2 (TSP2-null ECM) to render ...  
WO/2017/172469A1
A medical needle may include a lumen coating configured to reduce surface energy of the lumen-facing/ lumen defining surface, in a manner effective to slow and/or reduce coagulation of biomaterial (particularly blood) that contacts the n...  
WO/2017/156592A1
The present disclosure relates to anti-fouling and/or anti-thrombotic medical devices, methods for reducing fouling and/or thrombosis associated with medical devices, and methods for coating substrates to reduce fouling and/or thrombosis...  
WO/2017/150000A1
The objectives of the present invention are: to find a biocompatible material which has excellent film formation properties and resistance to water dissolution and is able to be easily coated to various bases, while having excellent anti...  
WO/2017/143419A1
The invention describes a method for producing nanozeolites with hemostatic activity comprising a nanoscale zeolite material derived from the faujasite family, treated with calcium, magnesium, barium and silver cations by an ion exchange...  
WO/2017/147491A1
The invention provides a method of producing a population of human Schwann cells. The method comprises (a) incubating human fascicles with one or more mitogens for a priming period of three to fourteen days to produce primed fascicles, (...  
WO/2017/146102A1
A device that includes: a substrate; and a hydrophilic polymer layer that comprises a hydrophilic polymer that has a hydroxyl group. The hydrophilic polymer layer that has a hydroxyl group is adhered to at least one portion of the surfac...  
WO/2017/146101A1
A device that includes: a substrate; and a gel layer that comprises a hydrophilic polymer that has a hydroxyl group. The gel layer is adhered to at least one portion of the surface of the substrate at a thickness of 1-3000 nm. The elasti...  
WO/2017/139224A1
Various embodiments relate to catheter locking solutions and catheter locking therapies with use of trisodium citrate and ethyl alcohol, and in particular 4.0 to 15.0 weight/volume % trisodium citrate as an anticoagulant component and/or...  
WO/2017/136268A1
Various embodiments of the present invention include a cannula coated or compounded with a material to extend the wear time for a patient by reducing inflammation and therefore increasing the time that the cannula may remain inserted, th...  
WO/2017/134049A1
Implantable medical product, comprising a basic body and an imidazole derivative in the form of its free base; wherein said basic body has on its polymeric surface a layer containing the imidazole derivative as an active ingredient, whic...  
WO/2017/131416A2
The present invention relates to a suturing thread for providing a more efficient lift procedure, and provides a suturing thread for a facelift and a body lift, wherein the suturing thread is made of a polymer material and has a pluralit...  
WO/2017/095782A1
In some embodiments, the present invention provides compositions including silk fibroin, at least one hydrophilic agent, and at least one catechol donating agent, wherein the at least one hydrophilic agent and at least one catechol donat...  
WO/2017/066242A1
A biocidally active polymer composition formed from an oligomeric or polymeric additive and a thermoplastic polyurethane polymer is disclosed. The biocidally active polymer may further include a non-fouling and/or non-thrombogenic polyme...  
WO/2017/047680A1
Provided is a photoreactive azide-containing copolymer having sufficient biocompatibility for use in medical material applications. Further provided is a production method that enables the photoreactive azide-containing copolymer to be s...  
WO/2017/039336A1
The present invention relates to a method for preparing a high-functional suture yarn coated with hyaluronate and a high-functional suture yarn prepared therefrom and, more specifically, to a method for preparing a high-functional suture...  
WO/2017/034223A1
The present invention relates to a silk suture with enhanced tensile strength and knot strength, and a manufacturing method therefor. The silk suture according to the present invention has enhanced tensile strength, knot strength and bio...  
WO/2017/027931A1
The present invention relates to the coating of a range of functional heparins onto the surface of a substrate for which hemocompatibility is a key functional characteristic, such that the functionality of the functional heparin is maint...  
WO/2017/019494A1
An implantable orthopedic device having an antimicrobial coating on at least one surface thereof is disclosed. The antimicrobial coating includes alexidine and a carrier polymer.  
WO/2017/019553A1
An embodiment includes a system comprising: a substrate of a medical device; an un-foamed polyurethane coating directly contacting the substrate and fixedly attached to the substrate; a thermoset polyurethane shape memory polymer (SMP) f...  
WO/2017/007430A1
Disclosed herein is a drug-coated medical device in the form of a balloon having an inner surface and an outer hydrophobic surface, an adhesion balance layer directly on the outer hydrophobic surface of the balloon, comprising a hydrophi...  
WO/2016/204217A1
Provided is a novel biocompatible material having improved biocompatibility. A biocompatible material comprising a fluoropolymer, said biocompatible material being characterized in that the fluoropolymer is a copolymer of a fluoroolefin ...  
WO/2016/201202A1
Medical devices, systems, and methods for treating conditions using antithrombin-heparin conjugates are disclosed. For example, medical devices can be coated with antithrombin-heparin (ATH) resulting in reduced thrombogenicity. Various c...  
WO/2016/196633A1
Techniques for modifying the surface of implantable devices, such as bioprosthetic valves, to improve the biocompatibility of the implantable devices are provided. In particular, a customizable, non-fouling surface coating may be formed ...  
WO/2016/187698A1
Provided herein are compositions comprising: (a) a polymeric catechol binder, such as: polymeric dopamine, polymeric norepinephrine, polymeric epinephrine; polymeric pyrogallol, polymeric tannic acid, polymeric hydroxyhydroquinone, polym...  
WO/2016/190407A1
The purpose of the present invention is to provide an antithrombotic material which exhibits high antithrombotic activity that is sustained over a long period, while reducing the thickness of the coating material. The present invention i...  
WO/2016/190202A1
Provided is a multi-ply tubular woven fabric structure that is useful as a base material of a hose for protecting a linear object such as a wire or cable for transporting a fluid or powder or a conduit tube, a tubular filter, an artifici...  
WO/2016/184872A1
The invention relates to a heparin-functionalized semi-permeable membrane comprising at least one layer of porous biocompatible polymer, and one layer of non-woven biocompatible polymer wherein said heparin is covalently bound to a layer...  
WO/2016/175548A1
The present invention relates to an anti-adhesion agent containing a natural biocompatible polymer and a DNA fragment mixture, and a preparation method therefor. The anti-adhesion agent of the present invention has an excellent effect of...  
WO/2016/168710A1
Compositions and methods for preventing thrombogenesis can include antithrombin and heparin. In one example, a conjugate of antithrombin and heparin where at least 50 wt% of the heparin is conjugated to antithrombin can be present. Furth...  
WO/2016/158388A1
The purpose of the present invention is to provide: a copolymer having blood compatibility and antithrombotic properties of greatly suppressing protein adhesion so as to be usable even when being in contact with a biological component su...  
WO/2016/159243A1
The present invention addresses the problem of providing an antithrombotic metallic material which has improved safety against low hemolytic toxicity and can exhibit high antithrombotic properties sustainably. The present invention provi...  
WO/2016/104596A1
Provided is a novel low protein adsorption material that resists protein adsorption and has excellent heat resistance, alkali resistance, and molding processability. The low protein adsorption material is characterized by comprising a fl...  
WO/2016/093230A1
This bodily-fluid-contacting medical tool has a coating film provided to a bodily-fluid-contacting surface thereof. The coating film includes a block polymer provided with: an acrylic polymer block formed from an acrylic monomer having a...  
WO/2016/083549A3
The present invention is related to the field of tissue regeneration. It concerns more particularly new standardizations and medical devices for the preparation of A-PRP, PRP, BMC, fat tissue, alone or in combination with a biomaterial o...  
WO/2016/073933A1
A suture anchor apparatus comprising: an anchoring member made from a metal-based material and comprising a generally elongated body having a proximal end and a distal end, wherein an outer surface of the anchoring member defines a threa...  
WO/2016/067795A1
[Problem] To provide: a material that is nonadhesive to biological substances, said material being capable of inhibiting or preventing adhesion of biological substances such as cells and blood components; a curing composition that is usa...  
WO/2016/061419A1
Nano- to microscale liquid coacervate particles are provided. The liquid coacervate particles are produced by a process including stimulating a population of liquid droplets containing one or a mixture of components to induce a phase sep...  
WO/2016/059024A1
A method for growing carbon nanowalls on a substrate of an implantable medical device by means of a processing chamber is provided, said method comprising: providing said substrate in said processing chamber, evacuating said processing c...  
WO/2016/044836A1
Microparticles containing heparin or a heparin-like polymer and a biocompatible polymer are described. The heparin or the heparin-like polymer and the biocompatible polymer can be indirectly linked together by a coupling agent, which can...  
WO/2016/037239A1
A plasma-activated coating (PAC) process covalently binds enzymes in their bioactive state, has low thrombogenicity and can be robustly applied to medical devices, resisting delamination when deployed in vivo. Applying this process to at...  
WO/2016/030358A1
According to the present invention a method which prevents excessive adsorption of microvesicles on the surfaces of tools used for sampling, storing and handling body flu- ids containing microvesicles is provided. The method comprises th...  
WO/2015/189716A1
Thrombosis resistant mechanical prosthetic heart valve is technical medical equipment. Thromboembolic is one of the most important complications of the available mechanical valves which may appear as a clot formation on the valve, its dy...  

Matches 1 - 50 out of 3,897